Related Experiment Video

Updated: Jul 14, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Congenital anomalies after prenatal ecstasy exposure

P R McElhatton, D N Bateman, C Evans

    Lancet (London, England)
    |October 30, 1999
    PubMed

    Insights

    Ecstasy (MDMA) exposure in utero may increase congenital defect risks in newborns. This prospective study found higher rates of cardiovascular and musculoskeletal anomalies in exposed infants.

    Area of Science:

    • Perinatal Medicine
    • Developmental Toxicology
    • Obstetrics

    Background:

    • Investigating the in utero effects of recreational drug use on fetal development is crucial for understanding potential health risks.
    • Ecstasy (3,4-methylenedioxymethamphetamine) is a widely used recreational drug with unknown long-term developmental impacts.
    • This study prospectively followed infants exposed to ecstasy during pregnancy.

    Discussion:

    • The findings suggest a potential association between prenatal ecstasy exposure and an increased incidence of congenital anomalies.
    • Cardiovascular and musculoskeletal anomalies were the most frequently observed defects, indicating potential teratogenic effects on specific organ systems.
    • The observed defect rate of 15.4% warrants further investigation into the dose-response relationship and specific vulnerable developmental periods.

    Key Insights:

    • Prospective follow-up of 136 infants exposed to ecstasy in utero revealed a significantly increased risk of congenital defects (15.4%).
    • Predominant anomalies included cardiovascular (26 per 1000 livebirths) and musculoskeletal (38 per 1000 livebirths) defects.
    • These findings highlight the potential teratogenic impact of ecstasy on fetal development.

    Outlook:

    • Further research is needed to confirm these findings and elucidate the precise mechanisms underlying ecstasy's teratogenicity.
    • Clinical guidelines for pregnant individuals using or considering ecstasy should be informed by these potential risks.
    • Long-term neurodevelopmental and behavioral outcomes in children exposed to ecstasy in utero require additional study.

    More Related Videos

    Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development15:27

    Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

    Published on: July 13, 2014

    Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

    Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

    Published on: November 20, 2015

    Related Concept Videos

    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    Drug Toxicity: Risk factors01:24

    Drug Toxicity: Risk factors

    Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...